血清炎性因子与冠脉罪犯病变纤维脂质斑块纤维帽厚度的相关性
该回顾性研究纳入117例冠心病患者,按临床类型分为SAP组47例、UAP组52例和NSTEMI组18例,检测术前血清hs-CRP和Lp-PLA2水平,并用OCT观察罪犯病变斑块性质。结果发现NSTEMI患者血清hs-CRP和Lp-PLA2水平最高,其薄纤维帽粥样斑块、斑块破裂和血栓形成比例也最高;血清hs-CRP和Lp-PLA2与纤维帽厚度呈负相关,Lp-PLA2是薄纤维帽粥样斑块的独立相关因素。
要点
- NSTEMI患者血清hs-CRP和Lp-PLA2水平高于UAP和SAP患者,UAP高于SAP。
- NSTEMI患者薄纤维帽粥样斑块、斑块破裂和血栓形成比例最高。
- 血清Lp-PLA2水平与薄纤维帽粥样斑块独立相关(OR=1.017,P<0.01)。
核心结论
- NSTEMI患者血清hs-CRP和Lp-PLA2水平高于SAP和UAP患者,UAP患者高于SAP患者。
- NSTEMI患者薄纤维帽粥样斑块、斑块破裂及血栓形成比例较高,SAP患者斑块钙化比例较高。
- 血清Lp-PLA2水平与薄纤维帽粥样斑块形成独立相关(OR=1.017,P<0.01)。
研究设计与样本
- 回顾性分析2015年1月至2016年1月择期行冠状动脉造影的冠心病患者117例。
- 按冠心病类型分为SAP组47例、UAP组52例和NSTEMI组18例。
- 术前检测血清hs-CRP和Lp-PLA2水平,介入治疗前用OCT观察罪犯病变斑块性质。
主要发现
- NSTEMI组血清hs-CRP为2.13(1.04, 4.75)μg/L,高于SAP组的1.02(0.60, 1.29)μg/L和UAP组的1.30(1.03, 1.96)μg/L(P均<0.05)。
- NSTEMI组血清Lp-PLA2为(394.8±61.4)mg/L,高于SAP组的(140.1±40.4)mg/L和UAP组的(284.5±93.6)mg/L(P均<0.05)。
- NSTEMI组和UAP组纤维帽厚度分别为50(50, 60)μm和60(50, 90)μm,均小于SAP组的130(80, 190)μm(P均<0.05)。
- NSTEMI组薄纤维帽粥样斑块比例为82.35%(14/18),高于SAP组的19.15%(9/47)和UAP组的63.46%(33/52)(P均<0.05)。
- Pearson相关分析显示,血清hs-CRP(r=-0.233,P<0.05)和Lp-PLA2(r=-0.465,P<0.01)与纤维帽厚度呈负相关。
关键数值与推荐
- 薄纤维帽粥样斑块定义为OCT检测的纤维帽厚度相关标准,原文未明确具体阈值。
- 多因素logistic回归显示血清Lp-PLA2水平与薄纤维帽粥样斑块独立相关(OR=1.017,P<0.01)。
临床怎么用
- 对于冠心病患者,血清hs-CRP和Lp-PLA2水平可辅助评估罪犯病变斑块易损性。
- Lp-PLA2水平升高提示薄纤维帽粥样斑块形成风险增加,可考虑作为风险分层参考。
局限性
- 本研究为单中心回顾性分析,样本量较小(共117例,NSTEMI组仅18例)。
- 原文未报告随访数据,无法评估炎性因子与临床预后的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To identify the correlation between serum inflammatory cytokine levels including high sensitive C reactive protein (hs-CRP) and lipoprotein associated phospholipase (Lp-PLA2) and the fibrous cap thickness of fibrofatty plaque in coronary culprit lesions. Methods: Clinical data of 117 patients with selective coronary artery angiography diagnosed coronary artery disease admitted to our hospital from January 2015 to January 2016 were retrospective analyzed. According to type of coronary disease, patients were divided into 3 subgroups: SAP group (containing 47 stable angina patients), UAP group (containing 52 unstable angina patients), and NSTEMI group(containing 18 acute non ST segment elevation myocardial infarction patients). Serum hs-CRP and Lp-PLA2 levels were measured before subsequent procedures. The characteristics of the culprit lesions were detected by optical coherence tomogarpgy(OCT) before interventional treatment, and the correlation between hs-CRP and Lp-PLA2 and the fibrous cap thickness of fibrofatty plaque in coronary culprit lesions were analyzed. Results: (1) The serum levels of hs-CRP (2.13(1.04, 4.75)μg/L vs. 1.02(0.60, 1.29)μg/L and 1.30(1.03, 1.96)μg/L, all P<0.05) and Lp-PLA2 ((394.8±61.4)mg/L vs. (140.1±40.4)mg/L and (284.5±93.6)mg/L, all P<0.05) were significantly higher in NSTEMI group than in SAP group and UAP group, and serum levels of hs-CRP and Lp-PLA2 were significantly higher in UAP group than in SAP group (all P<0.05). (2)The fibrous cap thickness of fibrofatty plaque in coronary culprit lesions were smaller in NSTEMI group and UAP group than in SAP group(50(50, 60)μm and 60(50, 90)μm vs. 130(80, 190)μm, all P<0.05), and there was no significantly difference between NSTEMI group and UAP group(P>0.05). Proportion of thin-cap fibroatheroma plaque(82.35%(14/18) vs. 19.15%(9/47) and 63.46%(33/52), all P<0.05), plaque rupture(55.56%(10/18)vs. 6.38%(3/47) and 28.85%(15/52), all P<0.05) and thrombosis(33.33%(6/18) vs. 4.26%(2/47) and 9.26%(5/52), all P<0.05) were significantly higher in NSTEMI group than in SAP group and UAP group. Proportion of calcifiacation in plaque was lower in NSTEMI group than in SAP group (11.11%(2/18)vs. 42.55%(20/47), P<0.05), and there was no significantly difference between NSTEMI group and UAP group(P>0.05). (3) Pearson correlation analysis showed that serum levels of hs-CRP(r=-0.233, P<0.05) and Lp-PLA2(r=-0.465, P<0.01)were negatively correlated with fibrous cap thickness of fibrofatty plaques. Spearman correlation analysis showed that serum levels of hs-CRP were positively correlated with plaque rupture(r=0.409, P<0.01) and thrombosis (r=0.227, P<0.05), and serum levels of Lp-PLA2 were also positively correlated with plaque rupture(r=0.499, P<0.01) and thrombosis(r=0.263, P<0.01). (4)Multiple logistic regression analysis showed that serum levels of Lp-PLA2 at baseline was independently related to thin-cap fibroatheroma plaque(OR=1.017, P<0.01). Conclusions: The serum levels of hs-CRP and Lp-PLA2 in NSTEMI patients are much higher than that in SAP and UAP patients, higher in UAP patients than in SAP patients. Prevalence of thin-cap fibroatheroma plaque, plaque rupture and thrombosis was significantly higher in the NSTEMI patients, while the prevalence of calcification in plaque is more often in SAP patients. Increased serum levels of Lp-PLA2 are independent risk factor of thin-cap fibroatheroma plaque formation. 目的: 探讨血清炎性因子高敏C反应蛋白(hs-CRP)、脂蛋白相关磷脂酶A2(Lp-PLA2)水平与冠状动脉罪犯病变纤维脂质斑块纤维帽厚度之间的相关性。 方法: 入选2015年1月至2016年1月在南京医科大学附属南京医院择期行冠状动脉造影的冠心病患者117例,对其临床资料进行回顾性分析。根据冠心病的类型,将患者分为稳定性心绞痛(SAP)组(47例)、不稳定性心绞痛(UAP)组(52例)和急性非ST段抬高型心肌梗死(NSTEMI)组(18例)。检测患者术前血清hs-CRP及Lp-PLA2水平,术中在介入治疗前使用光学相干断层成像(OCT)观察罪犯病变斑块性质,并分析血清hs-CRP及Lp-PLA2水平与纤维脂质斑块纤维帽厚度之间的关系。 结果: (1)NSTEMI组术前血清hs-CRP[2.13(1.04,4.75)μg/L比1.02(0.60,1.29)μg/L和1.30(1.03,1.96)μg/L,P均<0.05]和Lp-PLA2[(394.8±61.4)mg/L比(140.1±40.4)mg/L和(284.5±93.6)mg/L,P均<0.05]水平均高于SAP组和UAP组,UAP组术前血清hs-CRP和Lp-PLA2水平均高于SAP组(P均<0.05)。(2)NSTEMI组和UAP组的罪犯病变纤维脂质斑块纤维帽厚度均小于SAP组[50(50,60)μm和60(50,90)μm比130(80,190)μm,P均<0.05],NSTEMI组与UAP组之间的罪犯病变纤维脂质斑块纤维帽厚度差异无统计学意义(P>0.05)。NSTEMI组薄纤维帽粥样斑块[82.35%(14/18)比19.15%(9/47)和63.46%(33/52),P均<0.05]、斑块破裂[55.56%(10/18)比6.38%(3/47)和28.85%(15/52),P均<0.05]和血栓形成[33.33%(6/18)比4.26%(2/47)和9.26%(5/52),P均<0.05]的比率均高于SAP组和UAP组;NSTEMI组斑块内钙化的比率低于SAP组[11.11%(2/18)比42.55%(20/47),P<0.05],与UAP组[19.23%(10/52)]之间差异无统计学意义(P>0.05)。(3)Pearson相关分析显示,术前血清hs-CRP(r=-0.233,P<0.05)和Lp-PLA2(r=-0.465,P<0.01)水平与纤维脂质斑块纤维帽厚度均呈负相关;Spearman相关分析显示,术前血清hs-CRP水平与冠心病患者斑块破裂(r=0.409,P<0.01)和血栓形成(r=0.227,P<0.05)呈正相关;Spearman相关分析显示,术前血清Lp-PLA2水平与冠心病患者斑块破裂(r=0.499,P<0.01)和血栓形成(r=0.263,P<0.01)也呈正相关。(4)多因素logistic回归分析显示,血清Lp-PLA2水平与薄纤维帽粥样斑块独立相关(OR=1.017,P<0.01)。 结论: NSTEMI患者的血清hs-CRP和Lp-PLA2水平均高于SAP和UAP患者,UAP患者的血清hs-CRP和Lp-PLA2水平均高于SAP患者;NSTEMI、UAP和SAP患者罪犯病变的纤维脂质斑块性质有明显差别,NSTEMI患者出现薄纤维帽粥样斑块、斑块破裂及血栓形成的比例较高,而SAP患者出现斑块钙化的比例较高;血清Lp-PLA2水平与冠心病患者罪犯病变的薄纤维帽粥样斑块形成独立相关。.
引用
- Zhong Y, Ye F, You W, et al. [Correlation between serum inflammatory cytokine levels and fibrous cap thickness of fibrofatty plaque in coronary culprit lesions]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 28738484. doi:10.3760/cma.j.issn.0253-3758.2017.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。